ALS LIMITED (ALQ)
Share Price Analysis and Chart

Enter the company code or Name for stock analysis:

ALQ

ALQ - ALS LIMITED

FNArena Sector : Industrial Sector Contractors & Engineers
Year End: March
GICS Industry Group : Commercial & Professional Services
Debt/EBITDA: 1.88
Index: ASX100 | ASX200 | ASX300 | ALL-ORDS

ALS Ltd provides laboratory and testing services across the mining, industrial and life sciences sector. It operates in over 65 countries. Formerly Campbell Brothers Ltd it first listed in 1952 and changed name to ALS in 2012.

LAST PRICE CHANGE +/- CHANGE % VOLUME

$23.50

15 Jun
2026

0.960

OPEN

$23.65

4.26%

HIGH

$23.84

1,906,585

LOW

$23.21

TARGET
$25.38 8.0% upside
Franking for last dividend paid out: 30%
OTHER COMPANIES IN THE SAME SECTOR
AVD . BOL . BSA . BWN . CG1 . CLG . CVL . CWY . CXL . DOW . DUR . EGL . FLC . IPG . LBL . MAD . MPW . PPK . RWL . SDV . SHA . SND . SSM . SYL . TEA . VBC . VEE . VNT . VYS .
FNARENA'S MARKET CONSENSUS FORECASTS
ALQ: 1
Title FY25
Actual		 FY26
Actual		 FY27
Forecast		 FY28
Forecast
EPS (cps) xxx 65.7 90.7 xxx
DPS (cps) xxx 42.5 51.3 xxx
EPS Growth xxx 24.2% 38.0% xxx
DPS Growth xxx 10.1% 20.6% xxx
PE Ratio xxx N/A 25.6 xxx
Dividend Yield xxx N/A 2.2% xxx
Div Pay Ratio(%) xxx 64.7% 56.5% xxx

Dividend yield today if purchased 3 years ago: 3.63%

DIVIDEND YIELD CALCULATOR

Dividend Yield Today On Last Actual Payout :

 1.83

Estimated Dividend Growth
(Average Of Past Three Years)

  %

Amount Invested

 $ 

Tell Me The Dividend After This Many Years
Past performance is no guarantee for the future. Investors should take into account that heavy swings in share price or exceptional circumstances (a la 2009) can have a significant impact on short term calculations and averages

Last ex-div: 26/11 - ex-div 19.4c (franking 30%)

HISTORICAL DATA ARE ALL IN AUD
Copyright © 2026 FactSet UK Limited. All rights reserved
Title 202120222023202420252026
EPS Basic xxxxxxxxxxxxxxx65.7
DPS All xxxxxxxxxxxxxxx42.5
Sales/Revenue xxxxxxxxxxxxxxx3,320.1 M
Book Value Per Share xxxxxxxxxxxxxxx335.2
Net Operating Cash Flow xxxxxxxxxxxxxxx494.5 M
Net Profit Margin xxxxxxxxxxxxxxx9.60 %

EPS Basic

DPS All

Sales/Revenue

Book Value Per Share

Net Operating Cash Flow

Net Profit Margin

Title 202120222023202420252026
Return on Capital Employed xxxxxxxxxxxxxxx21.39 %
Return on Invested Capital xxxxxxxxxxxxxxx10.02 %
Return on Assets xxxxxxxxxxxxxxx7.89 %
Return on Equity xxxxxxxxxxxxxxx21.39 %
Return on Total Capital xxxxxxxxxxxxxxx17.49 %
Free Cash Flow ex dividends xxxxxxxxxxxxxxx37.9 M

Return on Capital Employed

Return on Invested Capital

Return on Assets

Return on Equity

Return on Total Capital

Free Cash Flow ex dividends

Title 202120222023202420252026
Short-Term Debt xxxxxxxxxxxxxxx117 M
Long Term Debt xxxxxxxxxxxxxxx1,455 M
Total Debt xxxxxxxxxxxxxxx1,572 M
Goodwill - Gross xxxxxxxxxxxxxxx-
Cash & Equivalents - Generic xxxxxxxxxxxxxxx150 M
Price To Book Value xxxxxxxxxxxxxxx6.20

Short-Term Debt

Long Term Debt

Total Debt

Goodwill - Gross

Cash & Equivalents - Generic

Price To Book Value

Title 202120222023202420252026
Capex xxxxxxxxxxxxxxx263.0 M
Capex % of Sales xxxxxxxxxxxxxxx7.92 %
Cost of Goods Sold xxxxxxxxxxxxxxx2,282 M
Selling, General & Admin. Exp & Other xxxxxxxxxxxxxxx455 M
Research & Development xxxxxxxxxxxxxxx-
Investments - Total xxxxxxxxxxxxxxx43 M

Capex

Capex % of Sales

Cost of Goods Sold

Selling, General & Admin. Exp & Other

Research & Development

Investments - Total

EXPERT VIEWS
Display All Commentary

Sentiment Indicator

0.9

No. Of Recommendations

5
BROKER DATE RATING RECOMMENDATION TARGET PRICE % TO REACH TARGET COMMENTARY

Ord Minnett

xx/xx/xxxx

2

xxxxxxxxxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

Bell Potter

xx/xx/xxxx

1

xxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

Morgans

19/05/2026

1

Buy

$27.20

15.74%

Morgans reckons ALS Ltd reported a robust 2H26 result with FY26 earnings (EBIT) up 18% y/y and net profit after tax growth rising 26% y/y.

Commodities was the stand out with Life Sciences the "laggard" albeit that came as no major surprise to the analyst post 1Q2026 results from overseas Life Sciences comparatives.

Commodities boosted by both earnings and margins rose 170bps in 2H to 29.5% versus the 1H26 at 27.8%.

Management flagged minerals growth (80% of commodities) to grow 13%-15% in FY27. The broker suggests the cadence is in line with underlying data.

No change in the target price of $27.20. The stock is Buy rated.

FORECAST
Morgans forecasts a full year FY27 dividend of 53.00 cents and EPS of 93.00 cents.
Morgans forecasts a full year FY28 dividend of 57.00 cents and EPS of 101.00 cents.

Macquarie

xx/xx/xxxx

1

xxxxxxxxxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

UBS

xx/xx/xxxx

1

xxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial
Access Stockbroker Research History >
EXTRA COVERAGE
Display All Commentary

No. Of Recommendations

1

Please note: unlike Broker Call Report, BC Extra is not updated daily. The info you see might not be the latest. FNArena does its best to update ASAP.

BROKER DATE RATING RECOMMENDATION TARGET PRICE % TO REACH TARGET COMMENTARY

Jarden

19/05/2026

4

Underweight

$18.90

-19.57%

Jarden maintains an Underweight rating for ALS Ltd while lifting the 12-month target price to $18.90 from $18.10 following changes to long-run earnings models.

The company delivered a FY26 core net profit after tax of $381m, marking 26% growth on the prior year.

Commentary highlights strong performance within the commodities division through the second half, offset ongoing structural volume challenges inside the North American environmental operations of the life sciences business.

Potential transaction risks from foreign exchange translation headwinds and a -$5m to -$10m procurement cost drag in the Middle East are expected to limit near-term outperformance.

Core earnings per share forecasts have been adjusted by -0.4% for FY27 and -1.2% for FY28, with current high relative trading multiples suggesting to Jarden the valuation is fully stretched.
Access Extra Coverage Research History >

ALQ STOCK CHART

FNArena News on ALQ

Latest Industrial Sector Contractors & Engineers News

1
New Growth Pathway for Cleanaway Waste Management

Mar 14 2022 - Australia
2
Better Times Ahead For Contractors

Sep 10 2021 - Australia
3
ALS Gathers Pace As Commodities Surge

May 27 2021 - Australia
4
Cash For Trash In Listed Waste Management

Apr 23 2021 - Weekly Reports
5
Lift In Exploration Augurs Well For ALS

Mar 11 2021 - Australia
6
Service Stream: Margin Pressure Versus NBN Upside

Mar 03 2021 - Australia
7
ALS To Benefit As Mineral Exploration Heats Up

Nov 19 2020 - Australia
8
Budget Puts Downer EDI In The Front Seat

Oct 08 2020 - Australia
9
ESG Focus: Of Waste And Resources

Sep 09 2020 - ESG Focus
10
ESG focus: Australia Gets Serious About Recycling

Jul 21 2020 - ESG Focus